Fertility and Sterility
Volume 92, Issue 4 , Pages 1389-1394 , October 2009

Blood ghrelin, resistin, and adiponectin concentrations during the normal menstrual cycle

  • Konstantinos Dafopoulos, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Thessalia, Larissa, Greece
    • ,
  • Dimitrios Sourlas, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Thessalia, Larissa, Greece
    • ,
  • Athanasios Kallitsaris, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Thessalia, Larissa, Greece
    • ,
  • Spyros Pournaras, M.D.

      Affiliations

    • Department of Microbiology, University of Thessalia, Larissa, Greece
    • ,
  • Ioannis E. Messinis, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Thessalia, Larissa, Greece
    • Corresponding Author InformationReprint requests: Ioannis E. Messinis, M.D., Ph.D., Department of Obstetrics and Gynecology, University of Thessalia, 22 Papakiriazi Street, 41222 Larissa, Greece (FAX: 302410670096).

Received 30 April 2008 ,Accepted 29 July 2008.

References 

  1. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 2001;86:4753–4758
  2. van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 2004;25:426–457
  3. Ghigo E, Broglio F, Arvat E, Maccario M, Papotti M, Muccioli G. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf). 2005;62:1–17
  4. Matsubara M, Sakata I, Wada R, Yamazaki M, Inoue K, Sakai T. Estrogen modulates ghrelin expression in the female rat stomach. Peptides. 2004;25:289–297
  5. Shibata K, Hosoda H, Kojima M, Kamgawa K, Makino Y, Makino I, et al. Regulation of ghrelin secretion during pregnancy and lactation in the rat: possible involvement of the hypothalamus. Peptides. 2004;25:279–287
  6. Gualillo O, Caminos JE, Kojima M, Kangawa K, Arvat E, Ghigo E, et al. Gender and gonadal influences on ghrelin mRNA levels in rat stomach. Eur J Endocrinol. 2001;144:687–690
  7. Makino Y, Hosoda H, Shibata K, Makino I, Kojima M, Kamgawa K, et al. Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy. Hypertension. 2002;39:781–784
  8. Lebenthal Y, Gat-Yablonski G, Shtaif B, Padoa A, Phillip M, Lazar L. Effect of sex hormone administration on circulating ghrelin levels in peripubertal children. J Clin Endocrinol Metab. 2006;91:328–331
  9. Grinspoon S, Miller KK, Herzog DB, Grieco KA, Klibanski A. Effects of estrogen and recombinant human insulin-like growth factor–I on ghrelin secretion in severe undernutrition. J Clin Endocrinol Metab. 2004;89:3988–3993
  10. Kellokoski E, Pöykkö SM, Karjalainen AH, Ukkola O, Heikkinen J, Kesäniemi YA, et al. Estrogen replacement therapy increases plasma ghrelin levels. J Clin Endocrinol Metab. 2005;90:2954–2963
  11. Chu MC, Cosper P, Nakhuda GS, Lobo RA. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Fertil Steril. 2006;86:1669–1675
  12. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79–83
  13. Hoffstedt J, Arvidsson E, Sjolin E, Wahlen K, Arner P. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab. 2004;89:1391–1396
  14. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46:459–469
  15. Yannakoulia M, Yiannakouris N, Bluher S, Matalas AL, Zacas DK, Mantzoros CS. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab. 2003;88:1730–1736
  16. Kleiblova P, Springer D, Haluzik M. The influence of hormonal changes during menstrual cycle on serum adiponectin concentrations in healthy women. Physiol Res. 2006;55:661–666
  17. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307–312
  18. Gui Y, Silha JV, Murphy LJ. Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes Res. 2004;12:1481–1491
  19. Nogueiras R, Gallego R, Gualillo O, Caminos JE, Garcia-Caballero T, Casanueva FF, et al. Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner. FEBS Lett. 2003;548:21–27
  20. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003;149:331–335
  21. Nogueiras R, Gualillo O, Caminos JE, Casanueva FF, Diequez C. Regulation of resistin by gonadal, thyroid hormone, and nutritional status. Obes Res. 2003;11:408–414
  22. Di Carlo C, Tommaselli GA, Gargano V, Sammartino A, Bifulco G, Tauchmanova L, et al. Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women. Menopause. 2007;14:1–7
  23. Chu M, Cosper P, Orio F, Carmina E, Lobo R. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. Am J Obstet Gynecol. 2006;194:100–104
  24. Hong SC, Yoo SW, Cho GJ, Kim T, Hur JY, Park YK, et al. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women. Menopause. 2007;14:835–840
  25. Rechberger T, Tomaszewski J, Pieprzowska-Bialek A, Kulik-Rechberger B, Skorupski P. Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene. Contraception. 2004;69:477–480
  26. Chalvatzas N, Dafopoulos K, Kosmas G, Kallitsaris A, Pournaras S, Messinis IE. Effect of ovarian hormones on serum adiponectin and resistin concentrations. Fertil Steril. Published online March 5, 2008.
  27. D'Eon TM, Souza SC, Aronovitz M, Martin S, Obin MS, Fried SK, et al. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem. 2005;280:35983–35991
  28. Huang SW, Seow KM, Ho LT, Chien Y, Chung DY, Chang CL, et al. Resistin mRNA levels are downregulated by estrogen in vivo and in vitro. FEBS Lett. 2005;579:449–454
  29. Chen YH, Lee MJ, Chang HH, Hung PF, Kao YH. 17 beta-estradiol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor, extracellularly regulated kinase, and CCAAT/enhancer binding protein-alpha pathways. Endocrinology. 2006;147:4496–4504
  30. Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, Orlova C, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab. 2003;88:4823–4831
  31. Jurimae J, Jurimae T. Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. Am J Physiol Endocrinol Metab. 2007;293:42–47
  32. Tamakoshi K, Yatsuya H, Wada K, Matsushita K, Otsuka R, Yang PO, et al. The transition to menopause reinforces adiponectin production and its contribution to improvement of insulin-resistant state. Clin Endocrinol (Oxf). 2007;66:65–71
  33. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002;51:2734–2741
  34. Sieminska L, Wojciechowska C, Niedziolka D, Marek B, Kos-Kudla B, Kajdaniuk D, et al. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metabolism. 2005;54:1610–1614
  35. Im JA, Lee JW, Lee HR, Lee DC. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy. Maturitas. 2006;54:65–71
  36. Tworoger S, Mantzoros C, Hankinson S. Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels. Obesity. 2007;15:2217–2224
  37. Laughlin GA, Barrett-Connor E, May S. Sex-specific association of the androgen to oestrogen ratio with adipocytokine levels in older adults: the Rancho Bernardo Study. Clin Endocrinol (Oxf). 2006;65:506–513
  38. Ibanez L, de Zegher F. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. J Clin Endocrinol Metab. 2004;89:1592–1597
  39. Sumino H, Takahashi T, Itoh T, Kusaka K, Yamakawa J, Ichikawa S, et al. Plasma adiponectin levels in post-menopausal women receiving hormone replacement therapy. J Int Med Res. 2004;32:639–645

 K.D. has nothing to disclose. D.S. has nothing to disclose. A.K. has nothing to disclose. S.P. has nothing to disclose. I.E.M. has nothing to disclose.

PII: S0015-0282(08)03297-4

doi: 10.1016/j.fertnstert.2008.07.1773

Fertility and Sterility
Volume 92, Issue 4 , Pages 1389-1394 , October 2009

Article Tools

* Image Usage & Resolution